MMedication Read More All You Need to Know About Sana (SANA) Rating Upgrade to BuyNovember 14, 2025 Investors might want to bet on Sana Biotechnology (SANA), as it has been recently upgraded to a Zacks…
GGenetics Read More Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to TreatmentAugust 11, 2025 Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys®…